52
Altrartis Therapeutics raises $11M in first capital round
Company raise · Closed · NEW YORK, NY · Form D filed 2026-10-22
Altrartis Therapeutics Inc., a Delaware corporation incorporated in 2025, raised $11M from 11 investors under Regulation D exemption 6(b). The offering closed on August 12, 2026, with no placement agent involved.
Note: Issuer incorporated in 2025, filed Form D in October 2026 after August 2026 first sale—typical lag for new companies. No industry detail beyond 'Other' in filing.
$10M+ raiseFirst raise on EDGARother
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Florian Brand | Executive Officer, Director, Promoter |
| Lars Christian Wilde | Director |
Signed by Florian Brand, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.